DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Robison NJ, Campigotto F, Chi SN. et al.
A phase II trial of a multi-agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer.
Pediatric blood & cancer 2014;
61: 636-642
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.